Canadian radiopharmaceutical firm DraxImage and biological drug discovery company Med Discovery have formed a research collaboration.
The companies will explore the combination of Med Discovery's targeted protein therapeutics with DraxImage's radiopharmaceutical activities, according to Med Discovery of Geneva, Switzerland, and DraxImage of Mississauga, Ontario.
The collaboration provides initially for radiolabeling of certain Med Discovery proteins by DraxImage to assess the enhancement of their therapeutic action and their capability to detect microtumors, the companies said.
By AuntMinnie.com staff writers
August 23, 2007
Related Reading
DraxImage files for European clearance, July 25, 2007
Draxis unveils management changes, July 20, 2007
Draxis posts Q2 earnings estimate, July 20, 2007
Draxis hires DeChambre for business development, May 29, 2007
Draxis to join Nasdaq Biotechnology Index, May 16, 2007
Copyright © 2007 AuntMinnie.com
